| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/12/2006 | US7105188 Fermentation solution of a sugar component, water, and a pine leaf cluster; allowing fermentation solution to stand for a period of time; treating atopic dermatitis and athlete's foot |
| 09/12/2006 | US7105184 Cosmetic and/or dermopharmaceutical preparations containing leaf extracts of the plant Argania spinosa |
| 09/12/2006 | US7105183 Treating amyotrophic lateral sclerosis (ALS); decreasing blood immune cell activation. |
| 09/12/2006 | US7105179 Crystal forms of azithromycin |
| 09/12/2006 | US7105170 comprises in vitro granuloma model containing fibroblasts for drug screening vaccines; kits |
| 09/12/2006 | US7105169 Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use |
| 09/12/2006 | CA2315110C Pellets having a core coated with an antifungal and a polymer |
| 09/12/2006 | CA2183549C Acidified nitrite as an antimicrobial agent |
| 09/12/2006 | CA2140929C Hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 09/12/2006 | CA2043932C Bacterin for the treatment of fusobacterium necrophorum diseases and a method for the production thereof |
| 09/09/2006 | CA2600359A1 Nucleosides with non-natural bases as anti-viral agents |
| 09/08/2006 | WO2006093987A1 Tricyclic-nucleoside compounds for treating viral infections |
| 09/08/2006 | WO2006093986A1 Tricyclic-nucleoside prodrugs for treating viral infections |
| 09/08/2006 | WO2006093801A1 Thiadiazine derivatives useful as anti-infective agents |
| 09/08/2006 | WO2006093784A2 Dosage forms of antibiotics and combinations of antibiotics ans symptomatic relief agents |
| 09/08/2006 | WO2006093745A1 Purification of rapamycin |
| 09/08/2006 | WO2006093329A1 Antimicrobial agent |
| 09/08/2006 | WO2006093267A1 Fermentation composition having immunomodulating effect |
| 09/08/2006 | WO2006093211A1 Anti-viral agent |
| 09/08/2006 | WO2006093164A1 Virus infection and proliferation inhibitor containing earthworm-derived component |
| 09/08/2006 | WO2006093071A1 ANTI-IDIOTYPE ANTIBODY HAVING ANTIFUNGAL ACTIVITY ON FUNGUS CARRYING β-GLUCAN SYNTHASE AND UTILIZATION OF THE SAME |
| 09/08/2006 | WO2006092822A2 4-fluorophenyl-derivatives of 1-{[1,5 -bis (4-chloro phenyl) -2-methyl-1h-pyrrol-3-yl]methyl} -4- methylpi pεrazine, synthesis process and uses thereof |
| 09/08/2006 | WO2006092608A1 Tricyclic derivatives of azetidine and pyrrole with antibacterial activity |
| 09/08/2006 | WO2006092599A2 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors |
| 09/08/2006 | WO2006092374A1 Antifungal compositions comprising sertaconazol and hydrocortisone and/or an antibacterial quinolone compound |
| 09/08/2006 | WO2006092334A1 Novel polymorph of mutilin |
| 09/08/2006 | WO2006092313A1 Lipopeptides having pharmaceutical activity |
| 09/08/2006 | WO2006092081A1 Insulin analogs from euphorbia lunulata extracts and the use thereof and the use of interleukin-10 analogs |
| 09/08/2006 | WO2006092059A1 Design and synthesis of novel antimicrobials |
| 09/08/2006 | WO2006078986A3 Quorum sensing modulators |
| 09/08/2006 | WO2006078904A3 Use of tetrazole derivatives as quorum sensing modulators |
| 09/08/2006 | WO2006041866A3 Prevention and treatment of hcv infection employing antibodies directed against conformational and linear epitopes |
| 09/08/2006 | CA2833783A1 Design and synthesis of novel antimicrobials |
| 09/08/2006 | CA2603534A1 Design and synthesis of novel antimicrobials |
| 09/08/2006 | CA2600118A1 Fermented compositions having immunomodulatory actions |
| 09/08/2006 | CA2599582A1 Purification of rapamycin |
| 09/08/2006 | CA2598668A1 Dosage forms of antibiotics and combinations of antibiotics and symptomatic relief agents |
| 09/08/2006 | CA2598598A1 Antifungal compositions comprising sertaconazol and hydrocortisone and/or an antibacterial quinolone compound |
| 09/08/2006 | CA2597685A1 Tricyclic-nucleoside compounds for treating viral infections |
| 09/08/2006 | CA2597683A1 Tricyclic-nucleoside prodrugs for treating viral infections |
| 09/07/2006 | US20060199957 Novel bicyclic and tricyclic cannabinoids |
| 09/07/2006 | US20060199956 Bicyclic heterocycles as HIV integrase inhibitors |
| 09/07/2006 | US20060199859 Topical medicaments and methods for photodynamic treatment of disease |
| 09/07/2006 | US20060199856 Dihydroorotate dehydrogenase (DHODH) inhibitors; Rheumatoid arthritis, Pneumocystis carinii, fibrosis, uveitis, rhinitis, asthma, and athropathy; 2-(Biphenyl-4-ylcarbamoyl)-cyclopent-1-enecarboxylic acid |
| 09/07/2006 | US20060199822 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 09/07/2006 | US20060199815 NK1 antagonists |
| 09/07/2006 | US20060199795 e.g. 2-[3,5-trans-5-(3-aminophenyl)-7-chloro-1-neopentyl-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-N-(2-fluorobenzyl)acetamide; G-protein-coupled receptor (TGR5) agonist; central nervous system diseases; antiinflammatory agent; learning enhancement; angina pectoris, arrhythmia, bronchial asthma |
| 09/07/2006 | US20060199791 Personal hygiene and hard surface cleaning agent; acne, skin complaints; effective against antibiotic resistant bacteria |
| 09/07/2006 | US20060199770 Functionalized carbon nanotubes, a process for preparing the same and their use in medicinal chemistry |
| 09/07/2006 | US20060198853 Papilloma virus capsomere vaccine formulations and methods of use |
| 09/07/2006 | US20060198840 increased in vivo half-lives due to the presence of an immunoglobulin G (IgG) constant domain; pharmacokinetics; diagnosis or immunotherapy; antibody conjugates; palivizumab |
| 09/07/2006 | DE102005008412A1 New piperazine salt of omeprazol is proton pump inhibitor useful to prevent/treat e.g. peptic ulcer, gastritis, gastroesophageal reflux, acute stress ulcer or dyspepsia |
| 09/06/2006 | EP1698701A1 Use of MHC class II ligands as adjuvant for vaccination and lag-3 in cancer treatment |
| 09/06/2006 | EP1698638A1 Lipopeptides having pharmaceutical activity |
| 09/06/2006 | EP1698630A1 New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations |
| 09/06/2006 | EP1698629A2 Polyamines and their use in therapy |
| 09/06/2006 | EP1698628A1 Hydroxypyrimidinone derivative having hiv integrase inhibitory activity |
| 09/06/2006 | EP1698627A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/06/2006 | EP1698347A2 hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 09/06/2006 | EP1698345A2 Peptide antagonists of zonulin and methods for use of the same |
| 09/06/2006 | EP1698342A1 Use of carbohydrates for eliminating intestinal infections in animals |
| 09/06/2006 | EP1698341A2 Use of carbohydrates for eliminating intestinal infections in animals |
| 09/06/2006 | EP1698336A1 Antifungal compositions comprising Sertaconazole and either Hydrocortisone or an antibacterial agent |
| 09/06/2006 | EP1698334A1 Pharmaceutically active isoindoline derivatives |
| 09/06/2006 | EP1698333A1 Fulvic acid and its use in the treatment of viral infections |
| 09/06/2006 | EP1697515A1 Dna-carrier conjugate |
| 09/06/2006 | EP1697400A1 Biphenyl-substituted antibacterial macrocycles |
| 09/06/2006 | EP1697392A1 Glycosylated triketide delta lactones |
| 09/06/2006 | EP1697382A2 Rifamycin analogs and uses thereof |
| 09/06/2006 | EP1697377A1 Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 09/06/2006 | EP1697348A1 Hiv protease inhibiting compounds |
| 09/06/2006 | EP1697347A1 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratiory syncytial virus replication |
| 09/06/2006 | EP1697345A1 Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 09/06/2006 | EP1697344A2 Hiv protease inhibiting compounds |
| 09/06/2006 | EP1697343A1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 09/06/2006 | EP1696934A1 Florfenicol prodrug having improved water solubility |
| 09/06/2006 | EP1696918A2 A method of treating hiv infection in atazanavir resistant patients using a combination of atazanavir and another protease inhibitor |
| 09/06/2006 | EP1696894A1 Treating infectious diseases using ice inhibitors |
| 09/06/2006 | EP1608757A4 Modified beta-lactamases and uses thereof |
| 09/06/2006 | EP1438042B1 Polymaleimide compounds and their medical use |
| 09/06/2006 | EP1406609B1 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 09/06/2006 | EP1401275B1 Antiviral composition and treatment method |
| 09/06/2006 | EP1349553B1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
| 09/06/2006 | EP1326632B1 Proteasome inhibitors for the treatment of hepatitis virus infections |
| 09/06/2006 | EP1257568B9 Novel echinocandin derivatives, preparation method and use thereof as fungicides |
| 09/06/2006 | EP1223933B1 5-membered heterocycle derivatives and use thereof as monoaminoxidase inhibitors |
| 09/06/2006 | EP1088075B1 Aav structural protein, production and use thereof |
| 09/06/2006 | EP0914341B1 Antagonists of intestinotrophic glp-2 peptides |
| 09/06/2006 | CN1829709A Bicyclic imidazol derivatives against flaviviridae |
| 09/06/2006 | CN1829512A Medicinal composition containing triazole compound |
| 09/06/2006 | CN1827646A Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies |
| 09/06/2006 | CN1827641A Antimicrobial polypeptide from Amolops loloensis and its pharmaceutical use |
| 09/06/2006 | CN1827638A Vancomycin and nor-vancomycin derivatives and their preparation process and use |
| 09/06/2006 | CN1827637A Antibacterial polypeptide from Amolops loloensis and its pharmaceutical use |
| 09/06/2006 | CN1827636A Protective polypeptide of human influenza A virus, its use, vaccine and diagnostic tool |
| 09/06/2006 | CN1827634A Nitrate derivatives of glycyrrhetic acid and glycyrrhetinic acid and pharmaceutical use thereof |
| 09/06/2006 | CN1827632A Process for purifying zidovudine palmitate raw materials and preparations thereof |
| 09/06/2006 | CN1827627A Novel acyclic nucleoside phosphonic acid and its ester derivatives and pharmaceutical use thereof |
| 09/06/2006 | CN1827617A Antivirus use of 17-(tetrahydrofuryl-2'-yl) methyl amine-17-demethoxy geldanamycin |
| 09/06/2006 | CN1827605A 4,4-disubstituted-3,4-dihydro-2(1H)- quinolones and synthesis process and use thereof |